Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Stefan Stortecky Added: 5 months ago
AHA 23 — We are joined onsite by Prof Stefan Stortecky (Bern University Hospital, Bern, SE) to discuss the findings of the single centre SPECIAL trial that investigated ultrasound-assisted catheter-directed thrombolysis as compared to surgical pulmonary embolectomy for intermediate high or high risk pulmonary embolism.Questions1. What is the reasoning behind this study?2. What is the patient… View more
Author(s): Nicolas Meneveau , Andrew SP Sharp , Adriaan Kraaijeveld Added: 5 years ago
Acoustic pulse thrombolysis treatment for pulmonary embolism patients: rationale, experience and data Satellite symposium at ESC Congress 2018 sponsored by EKOS Corporation Part 1: Prof Nicolas Meneveau - (Besancon, FR) Part 2: Prof Andrew Sharp - (Exeter, UK) Part 3: Prof Adriaan Kraaijeveld - (Utrecht, NL) View more
Author(s): Tito Kabir , Adel Aminian , Andrea Zuffi , et al Added: 3 years ago
The benefit of primary percutaneous coronary intervention (PCI) over hospital-based thrombolysis for ST-elevation myocardial infarction (STEMI) has been established beyond reasonable doubt.1 However, thrombolysis remains an effective and widely used therapy for a significant proportion of STEMI patients and is particularly effective within two hours of the onset of symptoms.2 There may also be… View more
Author(s): Roberto Sciagrà Added: 3 years ago
The best possible outcome in acute myocardial infarction (AMI) is the absence of any residual myocardial damage. This condition, usually obtained by early and effective reperfusion therapy, has been defined as aborted infarction.1 The classic diagnosis of aborted infarction is based on the detection of a minimal increase in cardiac enzymes together with a favourable evolution of the… View more
Job title: Chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group
Dr Marc S Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. He is also a professor of medicine at Harvard Medical School (HMS). Dr Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart… View more
Author(s): Pedro L Sánchez , Isaac Pascual Calleja , Héctor Bueno , et al Added: 3 years ago
The results of an electrocardiogram (ECG) on admission guide the next level of decision-making for the patient with chest pain suspected of myocardial ischaemia. If an occlusive thrombus forms, patients may develop an acute ST-segment-elevation myocardial infarction (STEMI), and the primary goal is to consider reperfusion therapy as quickly as possible. The benefit obtained by effective and early… View more
Author(s): Rainer Moosdorf Added: 3 years ago
Pulmonary embolism is mainly caused by deep venous thrombosis in the lower extremities, mostly due to longer immobilisation and/or restricted venous backflow. Thus, most patients have a typical history; however, symptoms may be misinterpreted and therapy delayed. While smaller or fragmented thrombi in the peripheral segments of the pulmonary arteries may only cause dyspnoea and hardly any… View more
Author(s): Stephen Ralph Large , David Phillip Jenkins Added: 3 years ago
There is emerging clarity in the management of pulmonary embolism (PE) as information has been collated to form guidelines addressing its diagnosis and management.1 This is appropriate as PE is common, and was observed in 18% of all autopsies in a recent Swedish study,1 with an incidence in hospital patients of 0.4%. It has a mortality rate of 7–11%,1 killing up to 10% of patients within the… View more
Job title: Associate Professor
Dr Stephen D Wiviott is senior investigator and chairman of the Clinical Events Committee with the Thrombolysis in Myocardial Infarction (TIMI) Study Group. In addition, he is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an associate professor of medicine at Harvard Medical School (HMS). Dr Wiviott’s research focuses on platelet function and antiplatelet… View more
Job title: Associate Physician
Dr Michelle O’Donoghue, is an Associate Physician in the Cardiology Division of Brigham and Women’s Hospital, an Affiliate Physician in the Cardiology Division of Massachusetts General Hospital and an Assistant Professor in Medicine at Harvard Medical School in Boston, Massachusetts, US. She is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, founded by Dr Eugene… View more